Information de reference pour ce titreAccession Number: | 00003837-201712000-00002.
|
Author: | Legeay, Samuel 1; Faure, Sebastien *,1
|
Institution: | (1)MINT, UNIV Angers, INSERM 1066, CNRS 6021 Universite Bretagne Loire IRIS-IBS-CHU 4 rue Larrey 49100 Angers France
|
Title: | |
Source: | Fundamental & Clinical Pharmacology. 31(6):594-609, December 2017.
|
Author Keywords: | bisphenol A; endocrine disruptor; environmental obesogenic compounds; obesity.
|
References: | 1. WHO . Challenges [Internet]. WHO. [cited 2017 Jan 30]. Available from: http://- ouverture dans une nouvelle fenêtre http://www.who.int/nutrition/cha...- ouverture dans une nouvelle fenêtre
2. Dhurandhar N.V., Schoeller D., Brown A.W., Heymsfield S.B., Thomas D., Sorensen T.I.A., et al. Energy balance measurement: when something is not better than nothing. Int. J. Obes. (2015) 39 1109-1113.
3. Baillie-Hamilton P.F. Chemical toxins: a hypothesis to explain the global obesity epidemic. J. Altern. Complement. Med. (2002) 8 185-192.
4. Holtcamp W. Obesogens: an environmental link to obesity. Environ. Health Perspect. (2012) 120 a62-a68.
5. Kelishadi R., Poursafa P., Jamshidi F. Role of environmental chemicals in obesity: a systematic review on the current evidence. J. Environ. Public Health. (2013) 2013 896789.
6. Colborn T., vom Saal F.S., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. (1993) 101 378-384.
7. WHO State of the science of endocrine disrupting chemicals - 2012 [Internet]. WHO. [cited 2017 Jan 6]. Available from: http://- ouverture dans une nouvelle fenêtre http://www.who.int/ceh/publicati...- ouverture dans une nouvelle fenêtre
8. Rochester J.R. Bisphenol A and human health: a review of the literature. Reprod. Toxicol. (2013) 42 132-155.
9. Chevalier N., Fenichel P. Bisphenol A: targeting metabolic tissues. Rev. Endocr. Metab. Disord. (2015) 16 299-309.
10. Janesick A.S., Blumberg B. Obesogens: an emerging threat to public health. Am. J. Obstet. Gynecol. (2016) 214 559-565.
11. Kirchner S., Kieu T., Chow C., Casey S., Blumberg B. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol. Endocrinol. Baltimore, MD (2010) 24 526-539.
12. Grun F., Watanabe H., Zamanian Z., Maeda L., Arima K., Cubacha R., et al. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol. Endocrinol. Baltimore, MD (2006) 20 2141-2155.
13. Grun F., Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev. Endocr. Metab. Disord. (2007) 8 161-171.
14. Legler J. An integrated approach to assess the role of chemical exposure in obesity. Obes. Silver Spring, MD (2013) 21 1084-1085.
15. Michalowicz J. Bisphenol A-sources, toxicity and biotransformation. Environ. Toxicol. Pharmacol. (2014) 37 738-758.
16. Huang Y.Q., Wong C.K.C., Zheng J.S., Bouwman H., Barra R., Wahlstrom B., et al. Bisphenol A (BPA) in China: a review of sources, environmental levels, and potential human health impacts. Environ. Int. (2012) 42 91-99.
17. Cao X.-L., Corriveau J., Popovic S. Sources of low concentrations of bisphenol A in canned beverage products. J. Food Prot. (2010) 73 1548-1551.
18. Dodson R.E., Nishioka M., Standley L.J., Perovich L.J., Brody J.G., Rudel R.A. Endocrine disruptors and asthma-associated chemicals in consumer products. Environ. Health Perspect. (2012) 120 935-943.
19. Geens T., Goeyens L., Kannan K., Neels H., Covaci A. Levels of bisphenol-A in thermal paper receipts from Belgium and estimation of human exposure. Sci. Total Environ. (2012) 435-436 30-33.
20. EFSA explains the Safety of Bisphenol A . European Food Safety Authority [Internet]. [cited 2016 Aug 29]. Available from: https://- ouverture dans une nouvelle fenêtre http://www.efsa.europa.eu/en/top...- ouverture dans une nouvelle fenêtre
21. Nutrition C for FS and A . Food Additives & Ingredients - Bisphenol A (BPA) [Internet]. [cited 2016 Aug 29]. Available from: http://- ouverture dans une nouvelle fenêtre http://www.fda.gov/Food/Ingredie...- ouverture dans une nouvelle fenêtre
22. Government of Canada HC . ARCHIVED - Health Risk Assessment of Bisphenol A from Food Packaging Applications [Internet]. 2008 [cited 2016 Aug 29]. Available from: http://- ouverture dans une nouvelle fenêtre http://www.hc-sc.gc.ca/fn-an/sec...- ouverture dans une nouvelle fenêtre
23. WHO . Toxicological and health aspects of bisphenol A [Internet]. WHO. [cited 2016 Aug 29]. Available from: http://- ouverture dans une nouvelle fenêtre http://www.who.int/foodsafety/pu...- ouverture dans une nouvelle fenêtre
24. Nam S.-H., Seo Y.-M., Kim M.-G. Bisphenol A migration from polycarbonate baby bottle with repeated use. Chemosphere (2010) 79 949-952.
25. Rajasarkka J., Pernica M., Kuta J., Lasnak J., Simek Z., Blaha L. Drinking water contaminants from epoxy resin-coated pipes: A field study. Water Res. (2016) 103 133-140.
26. Arnold S.M., Clark K.E., Staples C.A., Klecka G.M., Dimond S.S., Caspers N., et al. Relevance of drinking water as a source of human exposure to bisphenol A. J. Expo Sci. Environ. Epidemiol. (2013) 23 137-144.
27. Colin A., Bach C., Rosin C., Munoz J.-F., Dauchy X. Is drinking water a major route of human exposure to alkylphenol and bisphenol contaminants in France? Arch. Environ. Contam. Toxicol. (2014) 66 86-99.
28. Geens T., Roosens L., Neels H., Covaci A. Assessment of human exposure to Bisphenol-A, Triclosan and Tetrabromobisphenol-A through indoor dust intake in Belgium. Chemosphere (2009) 76 755-760.
29. Kang J.-H., Kondo F. Bisphenol A degradation in seawater is different from that in river water. Chemosphere (2005) 60 1288-1292.
30. Fox J.E., Gulledge J., Engelhaupt E., Burow M.E., McLachlan J.A. Pesticides reduce symbiotic efficiency of nitrogen-fixing rhizobia and host plants. Proc. Natl. Acad. Sci. U S A. (2007) 104 10282-10287.
31. Corrales J., Kristofco L.A., Steele W.B., Yates B.S., Breed C.S., Williams E.S., et al. Global assessment of bisphenol A in the environment: review and analysis of its occurrence and bioaccumulation. Dose-Response Publ. Int. Hormesis Soc. (2015) 13 1559325815598308.
32. Sajiki J., Takahashi K., Yonekubo J. Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. (1999) 736 255-261.
33. vom Saal F.S., Welshons W.V. Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine, and that BPA causes numerous hazards from multiple routes of exposure. Mol. Cell. Endocrinol. (2014) 398 101-113.
34. Savastano S., Tarantino G., D'Esposito V., Passaretti F., Cabaro S., Liotti A., et al. Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population. J. Transl. Med. (2015) 13 169.
35. Camarca A., Gianfrani C., Ariemma F., Cimmino I., Bruzzese D., Scerbo R., et al. Human peripheral blood mononuclear cell function and dendritic cell differentiation are affected by bisphenol-A exposure. PLoS ONE (2016) 11 e0161122.
36. Lee Y.J., Ryu H.-Y., Kim H.-K., Min C.S., Lee J.H., Kim E., et al. Maternal and fetal exposure to bisphenol A in Korea. Reprod. Toxicol. (2008) 25 413-419.
37. Fenichel P., Dechaux H., Harthe C., Gal J., Ferrari P., Pacini P., et al. Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes. Hum. Reprod. Oxf. Engl. (2012) 27 983-990.
38. Gerona R.R., Woodruff T.J., Dickenson C.A., Pan J., Schwartz J.M., Sen S., et al. Bisphenol-A (BPA), BPA glucuronide, and BPA sulfate in midgestation umbilical cord serum in a northern and central California population. Environ. Sci. Technol. (2013) 47 12477-12485.
39. Stojanoska M.M., Milosevic N., Milic N., Abenavoli L. The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders. Endocrine (2016) 55 666-681.
40. Volkel W., Colnot T., Csanady G.A., Filser J.G., Dekant W. Metabolism and kinetics of Bisphenol A in humans at low doses following oral administration. Chem. Res. Toxicol. (2002Oct 1) 15 1281-1287.
41. Fisher J.W., Twaddle N.C., Vanlandingham M., Doerge D.R. Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans. Toxicol. Appl. Pharmacol. (2011) 257 122-136.
42. Mazur C.S., Kenneke J.F., Hess-Wilson J.K., Lipscomb J.C. Differences between human and rat intestinal and hepatic bisphenol A glucuronidation and the influence of alamethicin on in vitro kinetic measurements. Drug Metab. Dispos. Biol. Fate Chem. (2010) 38 2232-2238.
43. Audebert M., Dolo L., Perdu E., Cravedi J.-P., Zalko D. Use of the [gamma]H2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines. Arch. Toxicol. (2011) 85 1463-1473.
44. Yang X., Fisher J.W. Unraveling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling. Front. Pharmacol. (2014) 5 292.
45. Snyder R.W., Maness S.C., Gaido K.W., Welsch F., Sumner S.C., Fennell T.R. Metabolism and disposition of bisphenol A in female rats. Toxicol. Appl. Pharmacol. (2000) 168 225-234.
46. Elsby R., Maggs J.L., Ashby J., Park B.K. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J. Pharmacol. Exp. Ther. (2001) 297 103-113.
47. Boucher J.G., Boudreau A., Ahmed S., Atlas E. In vitro effects of bisphenol A [beta]-D-glucuronide (BPA-G) on adipogenesis in human and murine preadipocytes. Environ. Health Perspect. (2015) 123 1287-1293.
48. Lakind J.S., Goodman M., Mattison D.R. Bisphenol A and indicators of obesity, glucose metabolism/type 2 diabetes and cardiovascular disease: a systematic review of epidemiologic research. Crit. Rev. Toxicol. (2014) 44 121-150.
49. Mirmira P., Evans-Molina C. Bisphenol A, obesity, and type 2 diabetes mellitus: genuine concern or unnecessary preoccupation? Transl. Res. J. Lab. Clin. Med. (2014) 164 13-21.
50. Oppeneer S.J., Robien K. Bisphenol A exposure and associations with obesity among adults: a critical review. Public Health Nutr. (2015) 18 1847-1863.
51. Braun J.M. Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. Nat. Rev. Endocrinol. (2016) 13 161-173.
52. Zhao H., Bi Y., Ma L., Zhao L., Wang T., Zhang L., et al. The effects of bisphenol A (BPA) exposure on fat mass and serum leptin concentrations have no impact on bone mineral densities in non-obese premenopausal women. Clin. Biochem. (2012) 45 1602-1606.
53. Pan H., Guo J., Su Z. Advances in understanding the interrelations between leptin resistance and obesity. Physiol. Behav. (2014) 130 157-169.
54. Mantzoros C.S., Magkos F., Brinkoetter M., Sienkiewicz E., Dardeno T.A., Kim S.-Y., et al. Leptin in human physiology and pathophysiology. Am. J. Physiol. Endocrinol. Metab. (2011) 301 E567-E584.
55. Ronn M., Lind L., Orberg J., Kullberg J., Soderberg S., Larsson A., et al. Bisphenol A is related to circulating levels of adiponectin, leptin and ghrelin, but not to fat mass or fat distribution in humans. Chemosphere (2014) 112 42-48.
56. Yildiz B.O., Suchard M.A., Wong M.-L., McCann S.M., Licinio J. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc. Natl. Acad. Sci. U S A. (2004) 101 10434-10439.
57. Tschop M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes (2001) 50 707-709.
58. Fu P., Kawamura K. Ubiquity of bisphenol A in the atmosphere. Environ. Pollut. Barking Essex 1987 (2010) 158 3138-3143.
59. Ye X., Wong L.-Y., Bishop A.M., Calafat A.M. Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ. Health Perspect. (2011) 119 983-988.
60. Trasande L., Attina T.M., Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA (2012) 308 1113-1121.
61. Wang H., Zhou Y., Tang C., Wu J., Chen Y., Jiang Q. Association between bisphenol A exposure and body mass index in Chinese school children: a cross-sectional study. Environ. Health Glob. Access. Sci. Source. (2012) 11 79.
62. Harley K.G., Aguilar Schall R., Chevrier J., Tyler K., Aguirre H., Bradman A., et al. Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environ. Health Perspect. (2013) 121 514-520.
63. Bhandari R., Xiao J., Shankar A. Urinary bisphenol A and obesity in U.S. children. Am. J. Epidemiol. (2013) 177 1263-1270.
64. Li D.-K., Miao M., Zhou Z., Wu C., Shi H., Liu X., et al. Urine bisphenol-A level in relation to obesity and overweight in school-age children. PLoS ONE (2013) 8 e65399.
65. Eng D.S., Lee J.M., Gebremariam A., Meeker J.D., Peterson K., Padmanabhan V. Bisphenol A and chronic disease risk factors in US children. Pediatrics (2013) 132 e637-e645.
66. Wells E.M., Jackson L.W., Koontz M.B. Association between bisphenol A and waist-to-height ratio among children: National Health and Nutrition Examination Survey, 2003-2010. Ann. Epidemiol. (2014) 24 165-167.
67. Choi J., Eom J., Kim J., Lee S., Kim Y. Association between some endocrine-disrupting chemicals and childhood obesity in biological samples of young girls: a cross-sectional study. Environ. Toxicol. Pharmacol. (2014) 38 51-57.
68. Philippat C., Mortamais M., Chevrier C., Petit C., Calafat A.M., Ye X., et al. Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ. Health Perspect. (2012) 120 464-470.
69. Braun J.M., Lanphear B.P., Calafat A.M., Deria S., Khoury J., Howe C.J., et al. Early-life bisphenol a exposure and child body mass index: a prospective cohort study. Environ. Health Perspect. (2014) 122 1239-1245.
70. Xue J., Wu Q., Sakthivel S., Pavithran P.V., Vasukutty J.R., Kannan K. Urinary levels of endocrine-disrupting chemicals, including bisphenols, bisphenol A diglycidyl ethers, benzophenones, parabens, and triclosan in obese and non-obese Indian children. Environ. Res. (2015) 137 120-128.
71. Agay-Shay K., Martinez D., Valvi D., Garcia-Esteban R., Basagana X., Robinson O., et al. Exposure to endocrine-disrupting chemicals during pregnancy and weight at 7 years of age: a multi-pollutant approach. Environ. Health Perspect. (2015) 123 1030-1037.
72. Vafeiadi M., Roumeliotaki T., Myridakis A., Chalkiadaki G., Fthenou E., Dermitzaki E., et al. Association of early life exposure to bisphenol A with obesity and cardiometabolic traits in childhood. Environ. Res. (2016) 146 379-387.
73. Hoepner L.A., Whyatt R.M., Widen E.M., Hassoun A., Oberfield S.E., Mueller N.T., et al. Bisphenol A and adiposity in an inner-city birth cohort. Environ. Health Perspect. (2016) 124 1644-1650.
74. De Lorenzo A., Soldati L., Sarlo F., Calvani M., Di Lorenzo N., Di Renzo L. New obesity classification criteria as a tool for bariatric surgery indication. World J. Gastroenterol. (2016) 22 681-703.
75. Roth J., Sahota N., Patel P., Mehdi S.F., Wiese M.M., Mahboob H.B., et al. Obesity paradox, obesity orthodox, and the metabolic syndrome: an approach to unity. Mol. Med. Cambridge, MA (2016) 22 873-885.
76. Stacy S.L., Eliot M., Calafat A.M., Chen A., Lanphear B.P., Hauser R., et al. Patterns, variability, and predictors of urinary bisphenol A concentrations during childhood. Environ. Sci. Technol. (2016) 50 5981-5990.
77. Menale C., Grandone A., Nicolucci C., Cirillo G., Crispi S., Di Sessa A., et al. Bisphenol A is associated with insulin resistance and modulates adiponectin and resistin gene expression in obese children. Pediatr. Obes. (2016) DOI: https://doi.org/10.1111/ijpo.121...- ouverture dans une nouvelle fenêtre
78. Ashley-Martin J., Dodds L., Arbuckle T.E., Ettinger A.S., Shapiro G.D., Fisher M., et al. A birth cohort study to investigate the association between prenatal phthalate and bisphenol A exposures and fetal markers of metabolic dysfunction. Environ. Health.[Internet] (2014) [cited 2016 Nov 25]13. Available from: https://www-ncbi-nlm-nih-gov.gat...- ouverture dans une nouvelle fenêtre
79. Marmugi A., Ducheix S., Lasserre F., Polizzi A., Paris A., Priymenko N., et al. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatol. Baltimore, MD (2012) 55 395-407.
80. Marmugi A., Lasserre F., Beuzelin D., Ducheix S., Huc L., Polizzi A., et al. Adverse effects of long-term exposure to bisphenol A during adulthood leading to hyperglycaemia and hypercholesterolemia in mice. Toxicology (2014) 325 133-143.
81. Kim M.J., Moon M.K., Kang G.H., Lee K.J., Choi S.H., Lim S., et al. Chronic exposure to bisphenol A can accelerate atherosclerosis in high-fat-fed apolipoprotein E knockout mice. Cardiovasc. Toxicol. (2014) 14 120-128.
82. Ding S., Fan Y., Zhao N., Yang H., Ye X., He D., et al. High-fat diet aggravates glucose homeostasis disorder caused by chronic exposure to bisphenol A. J. Endocrinol. (2014) 221 167-179.
83. Lai K.-P., Chung Y.-T., Li R., Wan H.-T., Wong C.K.-C. Bisphenol A alters gut microbiome: comparative metagenomics analysis. Environ. Pollut. Barking Essex 1987 (2016) 218 923-930.
84. Javurek A.B., Spollen W.G., Johnson S.A., Bivens N.J., Bromert K.H., Givan S.A., et al. Effects of exposure to bisphenol A and ethinyl estradiol on the gut microbiota of parents and their offspring in a rodent model. Gut. Microbes (2016) 7 471-485.
85. Koestel Z.L., Backus R.C., Tsuruta K., Spollen W.G., Johnson S.A., Javurek A.B., et al. Bisphenol A (BPA) in the serum of pet dogs following short-term consumption of canned dog food and potential health consequences of exposure to BPA. Sci. Total Environ. (2016) 579 1804-1814.
86. Schroeder B.O., Backhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat. Med. (2016) 22 1079-1089.
87. Sonnenburg J.L., Backhed F. Diet-microbiota interactions as moderators of human metabolism. Nature (2016) 535 56-64.
88. Ashby J., Tinwell H., Haseman J. Lack of effects for low dose levels of bisphenol A and diethylstilbestrol on the prostate gland of CF1 mice exposed in utero. Regul. Toxicol. Pharmacol. RTP. (1999) 30 156-166.
89. Cagen S.Z., Waechter J.M., Dimond S.S., Breslin W.J., Butala J.H., Jekat F.W., et al. Normal reproductive organ development in CF-1 mice following prenatal exposure to bisphenol A. Toxicol. Sci. (1999) 50 36-44.
90. Cagen S.Z., Waechter J.M., Dimond S.S., Breslin W.J., Butala J.H., Jekat F.W., et al. Normal reproductive organ development in Wistar rats exposed to bisphenol A in the drinking water. Regul. Toxicol. Pharmacol. RTP (1999) 30 130-139.
91. Howdeshell K.L., vom Saal F.S. Developmental exposure to bisphenol A: interaction with endogenous estradiol during pregnancy in mice. Am. Zool. (2000) 40 429-437.
92. Howdeshell K.L., Hotchkiss A.K., Thayer K.A., Vandenbergh J.G., vom Saal F.S. Environmental toxins: exposure to bisphenol A advances puberty. Nature (1999) 401 763-764.
93. Rubin B.S., Murray M.K., Damassa D.A., King J.C., Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect. (2001) 109 675-680.
94. Honma S., Suzuki A., Buchanan D.L., Katsu Y., Watanabe H., Iguchi T. Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod. Toxicol. Elmsford N. (2002) 16 117-122.
95. Nagao T., Saito Y., Usumi K., Yoshimura S., Ono H. Low-dose bisphenol A does not affect reproductive organs in estrogen-sensitive C57BL/6N mice exposed at the sexually mature, juvenile, or embryonic stage. Reprod. Toxicol. Elmsford N. (2002) 16 123-130.
96. Akingbemi B.T., Sottas C.M., Koulova A.I., Klinefelter G.R., Hardy M.P. Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology (2004) 145 592-603.
97. Nikaido Y., Yoshizawa K., Danbara N., Tsujita-Kyutoku M., Yuri T., Uehara N., et al. Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod. Toxicol. Elmsford N. (2004) 18 803-811.
98. Miyawaki J., Sakayama K., Kato H., Yamamoto H., Masuno H. Perinatal and postnatal exposure to bisphenol A increases adipose tissue mass and serum cholesterol level in mice. J. Atheroscler. Thromb. (2007) 14 245-252.
99. Howdeshell K.L., Furr J., Lambright C.R., Wilson V.S., Ryan B.C., Gray L.E. Gestational and lactational exposure to ethinyl estradiol, but not bisphenol A, decreases androgen-dependent reproductive organ weights and epididymal sperm abundance in the male long Evans hooded rat. Toxicol. Sci. (2008) 102 371-382.
100. Somm E., Schwitzgebel V.M., Toulotte A., Cederroth C.R., Combescure C., Nef S., et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ. Health Perspect. (2009) 117 1549-1555.
101. Alonso-Magdalena P., Vieira E., Soriano S., Menes L., Burks D., Quesada I., et al. Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ. Health Perspect. (2010) 118 1243-1250.
102. Ryan K.K., Haller A.M., Sorrell J.E., Woods S.C., Jandacek R.J., Seeley R.J. Perinatal exposure to bisphenol-A and the development of metabolic syndrome in CD-1 mice. Endocrinology (2010) 151 2603-2612.
103. Wei J., Lin Y., Li Y., Ying C., Chen J., Song L., et al. Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology (2011) 152 3049-3061.
104. Anderson O.S., Peterson K.E., Sanchez B.N., Zhang Z., Mancuso P., Dolinoy D.C. Perinatal bisphenol A exposure promotes hyperactivity, lean body composition, and hormonal responses across the murine life course. FASEB J. (2013) 27 1784-1792.
105. Angle B.M., Do R.P., Ponzi D., Stahlhut R.W., Drury B.E., Nagel S.C., et al. Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reprod. Toxicol. Elmsford N. (2013) 42 256-268.
106. Liu J., Yu P., Qian W., Li Y., Zhao J., Huan F., et al. Perinatal bisphenol A exposure and adult glucose homeostasis: identifying critical windows of exposure. PLoS ONE (2013) 8 e64143.
107. van Esterik J.C.J., Dolle M.E.T., Lamoree M.H., van Leeuwen S.P.J., Hamers T., Legler J., et al. Programming of metabolic effects in C57BL/6JxFVB mice by exposure to bisphenol A during gestation and lactation. Toxicology (2014) 321 40-52.
108. Johnson S.A., Painter M.S., Javurek A.B., Ellersieck M.R., Wiedmeyer C.E., Thyfault J.P., et al. Sex-dependent effects of developmental exposure to bisphenol A and ethinyl estradiol on metabolic parameters and voluntary physical activity. J. Dev. Orig. Health Dis. (2015) 6 539-552.
109. Rubin B.S., Paranjpe M., DaFonte T., Schaeberle C., Soto A.M., Obin M., et al. Perinatal BPA exposure alters body weight and composition in a dose specific and sex specific manner: the addition of peripubertal exposure exacerbates adverse effects in female mice. Reprod. Toxicol. Elmsford N. (2016) 68 130-144.
110. Garcia-Arevalo M., Alonso-Magdalena P., Servitja J.-M., Boronat-Belda T., Merino B., Villar-Pazos S., et al. Maternal exposure to bisphenol-A during pregnancy increases pancreatic [beta]-cell growth during early life in male mice offspring. Endocrinology (2016) 157 4158-4171.
111. Gao L., Wang H.N., Zhang L., Peng F.Y., Jia Y., Wei W., et al. Effect of perinatal bisphenol A exposure on serum lipids and lipid enzymes in offspring rats of different sex. Biomed. Environ. Sci. (2016) 29 686-689.
112. Thigpen J.E., Setchell K.D.R., Kissling G.E., Locklear J., Caviness G.F., Whiteside T., et al. The estrogenic content of rodent diets, bedding, cages, and water bottles and its effect on bisphenol A studies. J. Am. Assoc. Lab. Anim. Sci. (2013) 52 130-141.
113. Howdeshell K.L., Peterman P.H., Judy B.M., Taylor J.A., Orazio C.E., Ruhlen R.L., et al. Bisphenol A is released from used polycarbonate animal cages into water at room temperature. Environ. Health Perspect. (2003) 111 1180-1187.
114. Azzouz A., Ballesteros E. Trace analysis of endocrine disrupting compounds in environmental water samples by use of solid-phase extraction and gas chromatography with mass spectrometry detection. J. Chromatogr. A (2014) 1360 248-257.
115. Luo L., Liu M. Adipose tissue in control of metabolism. J. Endocrinol. (2016) 231 R77-R99.
116. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature (1998) 395 763-770.
117. Ahima R.S., Flier J.S. Leptin. Annu. Rev. Physiol. (2000) 62 413-437.
118. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. (1995) 1 1155-1161.
119. Porreca I., Ulloa-Severino L., Almeida P., Cuomo D., Nardone A., Falco G., et al. Molecular targets of developmental exposure to bisphenol A in diabesity: a focus on endoderm-derived organs. Obes. Rev. (2017) 18 99-108.
120. Masuno H., Kidani T., Sekiya K., Sakayama K., Shiosaka T., Yamamoto H., et al. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J. Lipid Res. (2002) 43 676-684.
121. Ohlstein J.F., Strong A.L., McLachlan J.A., Gimble J.M., Burow M.E., Bunnell B.A. Bisphenol A enhances adipogenic differentiation of human adipose stromal/stem cells. J. Mol. Endocrinol. (2014) 53 345-353.
122. Valentino R., D'Esposito V., Passaretti F., Liotti A., Cabaro S., Longo M., et al. Bisphenol-A impairs insulin action and up-regulates inflammatory pathways in human subcutaneous adipocytes and 3T3-L1 cells. PLoS ONE (2013) 8 e82099.
123. Dai Y.-E., Chen W., Qi H., Liu Q.-Q. Effect of bisphenol A on SOCS-3 and insulin signaling transduction in 3T3-L1 adipocytes. Mol. Med. Rep. (2016) 14 331-336.
124. Ariemma F., D'Esposito V., Liguoro D., Oriente F., Cabaro S., Liotti A., et al. Low-dose bisphenol-A impairs adipogenesis and generates dysfunctional 3T3-L1 adipocytes. PLoS ONE (2016) 11 e0150762.
125. Wetherill Y.B., Akingbemi B.T., Kanno J., McLachlan J.A., Nadal A., Sonnenschein C., et al. In vitro molecular mechanisms of bisphenol A action. Reprod. Toxicol. Elmsford N. (2007) 24 178-198.
126. Boucher J.G., Husain M., Rowan-Carroll A., Williams A., Yauk C.L., Atlas E. Identification of mechanisms of action of bisphenol A-induced human preadipocyte differentiation by transcriptional profiling. Obes. Silver Spring, MD. (2014) 22 2333-2343.
127. Boucher J.G., Boudreau A., Atlas E. Bisphenol A induces differentiation of human preadipocytes in the absence of glucocorticoid and is inhibited by an estrogen-receptor antagonist. Nutr. Diabetes (2014) 4 e102.
128. Atlas E., Pope L., Wade M.G., Kawata A., Boudreau A., Boucher J.G. Bisphenol A increases aP2 expression in 3T3L1 by enhancing the transcriptional activity of nuclear receptors at the promoter. Adipocyte (2014) 3 170-179.
129. Ahmed S., Atlas E. Bisphenol S- and bisphenol A-induced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma activation. Int. J. Obes. 2005 (2016) 40 1566-1573.
130. Ben-Jonathan N., Steinmetz R. Xenoestrogens: the emerging story of bisphenol a. Trends Endocrinol. Metab. (1998) 9 124-128.
131. Lu C., Cheng S.-Y. Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors. J. Mol. Endocrinol. (2010) 44 143-154.
132. Sargis R.M., Johnson D.N., Choudhury R.A., Brady M.J. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obes Silver Spring MD. (2010) 18 1283-1288.
133. Williams G. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-[alpha] and GPER signalling. Mol. Cell. Endocrinol. (2012) 351 269-278.
134. Ali A.T., Hochfeld W.E., Myburgh R., Pepper M.S. Adipocyte and adipogenesis. Eur. J. Cell Biol. (2013) 92 229-236.
135. Kidani T., Kamei S., Miyawaki J., Aizawa J., Sakayama K., Masuno H. Bisphenol A downregulates Akt signaling and inhibits adiponectin production and secretion in 3T3-L1 adipocytes. J. Atheroscler. Thromb. (2010) 17 834-843.
136. Hart R.J. Physiological aspects of female fertility: role of the environment, modern lifestyle, and genetics. Physiol. Rev. (2016) 96 873-909.
137. Deb P., Bhan A., Hussain I., Ansari K.I., Bobzean S.A., Pandita T.K., et al. Endocrine disrupting chemical, bisphenol-A, induces breast cancer associated gene HOXB9 expression in vitro and in vivo. Gene (2016) 590 234-243.
138. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 316 889-894.
139. Scuteri A., Sanna S., Chen W.-M., Uda M., Albai G., Strait J., et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. (2007) 3 e115.
140. Singh R.K., Kumar P., Mahalingam K. Molecular genetics of human obesity: a comprehensive review. C R Biol. (2017) 340 87-108.
141. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U S A (2009) 106 9362-9367.
142. Goldberg A.D., Allis C.D., Bernstein E. Epigenetics: a landscape takes shape. Cell (2007) 128 635-638.
143. Desai M., Jellyman J.K., Ross M.G. Epigenomics, gestational programming and risk of metabolic syndrome. Int. J. Obes. 2005 (2015) 39 633-641.
144. Doshi T., Mehta S.S., Dighe V., Balasinor N., Vanage G. Hypermethylation of estrogen receptor promoter region in adult testis of rats exposed neonatally to bisphenol A. Toxicology (2011) 289 74-82.
145. Dolinoy D.C., Huang D., Jirtle R.L. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc. Natl Acad. Sci. (2007) 104 13056-13061.
146. Warita K., Mitsuhashi T., Ohta K., Suzuki S., Hoshi N., Miki T., et al. Gene expression of epigenetic regulatory factors related to primary silencing mechanism is less susceptible to lower doses of bisphenol A in embryonic hypothalamic cells. J. Toxicol. Sci. (2013) 38 285-289.
147. Ross M.G., Desai M. Developmental programming of offspring obesity, adipogenesis, and appetite. Clin. Obstet. Gynecol. (2013) 56 529.
148. Rosenmai A.K., Dybdahl M., Pedersen M., Alice van Vugt-Lussenburg B.M., Wedebye E.B., Taxvig C., et al. Are structural analogues to bisphenol a safe alternatives? Toxicol. Sci. (2014) 139 35-47.
149. Grignard E., Lapenna S., Bremer S. Weak estrogenic transcriptional activities of bisphenol A and bisphenol S. Toxicol. Vitro (2012) 26 727-731.
150. Liu J., Li J., Wu Y., Zhao Y., Luo F., Li S., et al. Bisphenol A metabolites and bisphenol S in paired maternal and cord serum. Environ. Sci. Technol. (2017) 51 2456-2463.
151. Rochester J.R., Bolden A.L. Bisphenol S and F: a systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ. Health Perspect. (2015) 123 643-650.
152. Pivnenko K., Pedersen G.A., Eriksson E., Astrup T.F. Bisphenol A and its structural analogues in household waste paper. Waste Manag. (2015) 44 39-47.
153. Ivry Del Moral L., Le Corre L., Poirier H., Niot I., Truntzer T., Merlin J.-F., et al. Obesogen effects after perinatal exposure of 4,4'-sulfonyldiphenol (Bisphenol S) in C57BL/6 mice. Toxicology (2016) 357-358 11-20.
154. Helies-Toussaint C., Peyre L., Costanzo C., Chagnon M.-C., Rahmani R. Is bisphenol S a safe substitute for bisphenol A in terms of metabolic function? An in vitro study. Toxicol. Appl. Pharmacol. (2014) 280 224-235.
155. Heindel J.J., Newbold R., Schug T.T. Endocrine disruptors and obesity. Nat. Rev. Endocrinol. (2015) 11 653-661.
156. Heindel J.J., Schug T.T. The perfect storm for obesity. Obesity (2013) 21 1079-1080.
|
Language: | English.
|
Document Type: | REVIEW ARTICLE.
|
Journal Subset: | Pharmacology.
|
ISSN: | 0767-3981
|
NLM Journal Code: | f8s, 8710411
|
DOI Number: | https://dx.doi.org/10.1111/fcp.1...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|